title: [Surgical strategy in active infective endocarditis].
abstract: In the cardio-surgical department of the regional clinical hospital of Kirov oblast 117 patients (83 men and 34 women) with active infective endocarditis of native heart valves were operated upon: with injury of the aortal valve (61), mitral (37), mitral and aortal (16), tricuspidal (2), mitral, aortal and tricuspidal (1). During 10 days the patients were examined and prepared for operation which included intensive antibacterial, cardiotropic and immunomodulating therapy. Then the operation of prosthesing the valve, mainly with domestic prostheses "LIKS-2" and Karboniks-1 was performed. Lethality was 7.6%. Recurrent endocarditis took place in 6% of cases. In reoperations cannulation of the femoral artery and retrograde cardioplegia were used. In repeated mitral prosthesing right side thoracotomy in the 4th intercostal area was used as the approach. The surgical strategy for active infective endocarditis should consist of maximally rapid examination of the patient, rapid intensive preparation for the operation performed in maximally early terms.
authors.forename: V A
authors.initials: VA
authors.lastname: Viaznikov
authors.forename: O A
authors.initials: OA
authors.lastname: Derbenev
mesh_terms: D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D006348:Cardiac Surgical Procedures / Q000379:methods*; D003131:Combined Modality Therapy; D004697:Endocarditis, Bacterial / Q000188:drug therapy / Q000534:rehabilitation / Q000601:surgery*; D004867:Equipment Design; D005260:Female; D019918:Heart Valve Prosthesis Implantation / Q000295:instrumentation; D006760:Hospitalization; D006801:Humans; D007902:Length of Stay; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use
chemical_list: D000890:Anti-Infective Agents; D008795:Metronidazole